salbutamol
salbutamol.JPG

CLINICAL USE

Beta2-adrenoceptor agonist:Reversible airways disease

DOSE IN NORMAL RENAL FUNCTION

Oral: 2–4 mg 3–4 times daily SC/IM: 500 micrograms, repeated 4 hourly if necessaryIV: 250 micrograms slow bolus, repeated if requiredInfusion: start with 5 micrograms/minute, adjust according to response, usually 3–20 micrograms/minuteAerosol: 100–200 micrograms (1–2 puffs) 4 times dailyPowder: 200–400 micrograms 4 times dailyNebulisation: 2.5–5 mg 4 times daily, or more frequently

PHARMACOKINETICS

  • Molecular weight                           :239.3
  • %Protein binding                           :10
  • %Excreted unchanged in urine     : 51–64
  • Volume of distribution (L/kg)       :2–2.5
  • half-life – normal/ESRD (hrs)      :4–6/Unchanged

    DOSE IN RENAL IMPAIRMENT

    GFR (mL/MIN)

  • 20 to 50     : Dose as in normal renal function
  • 10 to 20     : Dose as in normal renal function
  • <10           : Dose as in normal renal function

    DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES

  • CAPD                :Unknown dialysability. Dose as in normal renal function
  • HD                     :Unknown dialysability. Dose as in normal renal function
  • HDF/high flux   :Unknown dialysability. Dose as in normal renal function
  • CAV/VVHD      :Unknown dialysability. Dose as in normal renal function

    IMPORTANT DRUG INTERACTIONS

    Potentially hazardous interactions with other drugsIncreased risk of hypokalaemia when diuretics, theophylline or large doses of corticosteroids are given with high doses of salbutamolAntihypertensives: acute hypotension with

    IV infusion

    of salbutamol and methyldopa

    ADMINISTRATION

    Reconstition

    Route

    IV, SC, IM, oral, inhaled, nebulised

    Rate of Administration

    IV slow bolus;

    IV infusion

    3–20 micrograms/minute

    Comments

    Infusion: dilute 10 mL (10 mg) to 500 mL with sodium chloride 0.9% or glucose 5% (20 micrograms/mL)Via syringe pump: dilute 10 mL (10 mg) to 50 mL with sodium chloride 0.9% or glucose 5% (200 micrograms/mL)

    OTHER INFORMATION

    Monitor ECG/BP/pulse Nebulised salbutamol may be prescribed for hypokalaemic effect in acute hyperkalaemia (unlicensed).



    See how to identify renal failure stages according to GFR calculation

    See how to diagnose irreversible renal disease

    Home

  • other drugs